• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核衣壳蛋白(N)的刺突特异性抗体反应在全病毒疫苗中的独立保护作用及影响

Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines.

作者信息

Yang Huijie, Xie Ying, Lu Shuaiyao, Sun Yufang, Wang Kaiqin, Li Shuyan, Wang Junzhi, Liao Guoyang, Li Changgui

机构信息

Divsion of Respiratory Virus Vaccines, National Institutes for Food and Drug Control, Beijing 102629, China.

Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650108, China.

出版信息

Vaccines (Basel). 2023 Nov 2;11(11):1681. doi: 10.3390/vaccines11111681.

DOI:10.3390/vaccines11111681
PMID:38006013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10675215/
Abstract

Of all of the components in SARS-CoV-2 inactivated vaccines, nucleocapsid protein (N) is the most abundant and highly conserved protein. However, the function of N in these vaccines, especially its influence on the targeted spike protein's response, remains unknown. In this study, the immunization of mice with the N protein alone was shown to reduce the viral load, alleviating pulmonary pathological lesions after challenge with the SARS-CoV-2 virus. In addition, co-immunization and pre-immunization with N were found to induce higher S-specific antibody titers rather than compromise them. Remarkably, the same trend was also observed when N was administered as the booster dose after whole inactivated virus vaccination. N-specific IFN-γ-secreting T cell response was detected in all groups and exhibited a certain relationship with S-specific IgG antibody improvements. Together, these data indicate that N has an independent role in vaccine-induced protection and improves the S-specific antibody response to inactivated vaccines, revealing that an interplay mechanism may exist in the immune responses to complex virus components.

摘要

在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)灭活疫苗的所有成分中,核衣壳蛋白(N)是含量最丰富且高度保守的蛋白。然而,N在这些疫苗中的功能,尤其是其对靶向刺突蛋白反应的影响,仍然未知。在本研究中,单独用N蛋白免疫小鼠可降低病毒载量,减轻感染SARS-CoV-2病毒后的肺部病理损伤。此外,发现用N进行联合免疫和预免疫可诱导更高的S特异性抗体滴度,而非损害它们。值得注意的是,在全病毒灭活疫苗接种后以N作为加强剂量时也观察到了相同趋势。在所有组中均检测到了N特异性分泌γ干扰素的T细胞反应,且其与S特异性IgG抗体的改善存在一定关系。总之,这些数据表明N在疫苗诱导的保护中具有独立作用,并改善了对灭活疫苗的S特异性抗体反应,揭示了对复杂病毒成分的免疫反应中可能存在相互作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176f/10675215/0a5f0389daf5/vaccines-11-01681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176f/10675215/6159aabdea92/vaccines-11-01681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176f/10675215/885b19889c3b/vaccines-11-01681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176f/10675215/0a5f0389daf5/vaccines-11-01681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176f/10675215/6159aabdea92/vaccines-11-01681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176f/10675215/885b19889c3b/vaccines-11-01681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176f/10675215/0a5f0389daf5/vaccines-11-01681-g003.jpg

相似文献

1
Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核衣壳蛋白(N)的刺突特异性抗体反应在全病毒疫苗中的独立保护作用及影响
Vaccines (Basel). 2023 Nov 2;11(11):1681. doi: 10.3390/vaccines11111681.
2
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
3
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.单次免疫表达刺突蛋白和核衣壳蛋白的重组 ACAM2000 痘苗病毒可保护仓鼠免受 SARS-CoV-2 引起的临床疾病。
J Virol. 2022 May 11;96(9):e0038922. doi: 10.1128/jvi.00389-22. Epub 2022 Apr 12.
4
Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins.基于外泌体的多价疫苗:用纳克级蛋白质实现有效的免疫接种、广泛的反应性和强烈的 T 细胞反应。
Microbiol Spectr. 2023 Jun 15;11(3):e0050323. doi: 10.1128/spectrum.00503-23. Epub 2023 Apr 24.
5
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
6
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial.在接种一剂灭活全病毒 COVID-19 疫苗(VLA2001)加强针后针对原始株、Delta 株和奥密克戎株变异病毒的安全性和免疫原性:COV-COMPARE 随机对照 3 期试验开放标签扩展的中期分析。
J Infect. 2023 Sep;87(3):242-254. doi: 10.1016/j.jinf.2023.06.022. Epub 2023 Jul 3.
7
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine.口服亚单位 SARS-CoV-2 疫苗可诱导全身中和 IgG、IgA 和细胞免疫应答,并能增强已接种疫苗产生的中和抗体应答。
Vaccine. 2022 Feb 16;40(8):1098-1107. doi: 10.1016/j.vaccine.2022.01.025. Epub 2022 Jan 19.
8
Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.严重急性呼吸综合征疫苗研发:针对禽传染性支气管炎冠状病毒的疫苗接种经验
Avian Pathol. 2003 Dec;32(6):567-82. doi: 10.1080/03079450310001621198.
9
Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV.在 HIV 感染者中,不同的 SARS-CoV-2 疫苗平台可诱导产生稳健的疫苗诱导的体液免疫和细胞免疫反应。
Microbiol Spectr. 2023 Jun 15;11(3):e0115523. doi: 10.1128/spectrum.01155-23. Epub 2023 May 11.
10
A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.皮下注射紫外线灭活的严重急性呼吸综合征冠状病毒疫苗可在小鼠体内引发全身性体液免疫。
Int Immunol. 2004 Oct;16(10):1423-30. doi: 10.1093/intimm/dxh143. Epub 2004 Aug 16.

引用本文的文献

1
Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency.异源加强免疫接种通过改善 TFH 功能和增加 B 细胞克隆型 SHM 频率来增强对 SARS-CoV-2 的抗体反应。
Front Immunol. 2024 Jun 21;15:1406138. doi: 10.3389/fimmu.2024.1406138. eCollection 2024.
2
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein.提高下一代 COVID-19 疫苗免疫原性的关键在于包含 SARS-CoV-2 核衣壳蛋白。
J Immunol Res. 2024 May 29;2024:9313267. doi: 10.1155/2024/9313267. eCollection 2024.
3

本文引用的文献

1
Study of the Effects of Several SARS-CoV-2 Structural Proteins on Antiviral Immunity.几种新冠病毒结构蛋白对抗病毒免疫的影响研究
Vaccines (Basel). 2023 Feb 23;11(3):524. doi: 10.3390/vaccines11030524.
2
Molecular fate-mapping of serum antibody responses to repeat immunization.血清抗体对重复免疫反应的分子命运图谱。
Nature. 2023 Mar;615(7952):482-489. doi: 10.1038/s41586-023-05715-3. Epub 2023 Jan 16.
3
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity.抗原进化和原始抗原致敏对 SARS-CoV-2 免疫的影响。
Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice.
基于 SARS-CoV-2 刺突蛋白的鼻内疫苗在小鼠初次和加强免疫中的免疫原性。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2364519. doi: 10.1080/21645515.2024.2364519. Epub 2024 Jun 16.
4
The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice.CpG、MF59样和铝佐剂δ株灭活新型冠状病毒疫苗在小鼠中的免疫原性
Vaccines (Basel). 2024 Jan 7;12(1):60. doi: 10.3390/vaccines12010060.
J Clin Invest. 2023 Jan 3;133(1):e162192. doi: 10.1172/JCI162192.
4
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong.三剂疫苗接种诱导的免疫反应可预防新冠病毒奥密克戎BA.2:香港一项基于人群的研究
Lancet Reg Health West Pac. 2023 Mar;32:100660. doi: 10.1016/j.lanwpc.2022.100660. Epub 2022 Dec 23.
5
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models.双刺突和核衣壳 mRNA 疫苗接种可预防临床前模型中的 SARS-CoV-2 奥密克戎和德尔塔变异株。
Sci Transl Med. 2022 Sep 14;14(662):eabq1945. doi: 10.1126/scitranslmed.abq1945.
6
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial.在中国,一种灭活的 SARS-CoV-2 疫苗(国药 BBIBP-CorV)与四价裂解流感疫苗和 23 价肺炎球菌多糖疫苗联合接种的免疫原性和安全性:一项多中心、非劣效性、开放性、随机、对照、四期临床试验。
Vaccine. 2022 Aug 26;40(36):5322-5332. doi: 10.1016/j.vaccine.2022.07.033. Epub 2022 Jul 29.
7
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants.一种多表位 SARS-CoV-2 疫苗可提供针对 Delta 和奥密克戎变异株的持久 B 细胞和 T 细胞免疫。
J Clin Invest. 2022 May 16;132(10). doi: 10.1172/JCI157707.
8
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials.科兴新冠疫苗加强免疫的免疫原性和安全性,以及两剂接种程序的免疫持久性:两项单中心、双盲、随机、安慰剂对照的 2 期临床试验的中期结果。
Lancet Infect Dis. 2022 Apr;22(4):483-495. doi: 10.1016/S1473-3099(21)00681-2. Epub 2021 Dec 8.
9
Covid-19 vaccines and variants of concern: A review.Covid-19 疫苗和关注变种:综述。
Rev Med Virol. 2022 Jul;32(4):e2313. doi: 10.1002/rmv.2313. Epub 2021 Nov 9.
10
SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration.SARS-CoV-2 跨越血脑屏障伴随着基膜破坏而没有紧密连接的改变。
Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.